Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
TF Stoop, RT Theijse, LWF Seelen… - Nature Reviews …, 2024 - nature.com
Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for
patients with localized pancreatic cancer. Upfront surgery is considered suboptimal in cases …
patients with localized pancreatic cancer. Upfront surgery is considered suboptimal in cases …
[HTML][HTML] Nutrition in cancer patients
P Ravasco - Journal of clinical medicine, 2019 - mdpi.com
Background: Despite being recognised that nutritional intervention is essential, nutritional
support is not widely accessible to all patients. Given the incidence of nutritional risk and …
support is not widely accessible to all patients. Given the incidence of nutritional risk and …
[HTML][HTML] Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials
JL van Dam, QP Janssen, MG Besselink… - European Journal of …, 2022 - Elsevier
Introduction Neoadjuvant therapy may improve survival compared with upfront surgery in
patients with resectable and borderline resectable pancreatic cancer, but high-quality …
patients with resectable and borderline resectable pancreatic cancer, but high-quality …
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment
R De Luca, L Gianotti, P Pedrazzoli, O Brunetti… - European Journal of …, 2023 - Elsevier
Pancreatic cancer (PC) is an aggressive disease, with a growing incidence, and a poor
prognosis. Neoadjuvant treatments in PC are highly recommended in borderline resectable …
prognosis. Neoadjuvant treatments in PC are highly recommended in borderline resectable …
Pancreatic cancer: An update on diagnosis and management
BPT Loveday, L Lipton… - Australian journal of …, 2019 - search.informit.org
Background: Pancreatic cancer has the highest mortality rate among all main cancer types
and is the fourth leading cause of cancer death in Australia. Objective: This review focuses …
and is the fourth leading cause of cancer death in Australia. Objective: This review focuses …
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international …
W Greenhalf, P Lévy, T Gress, V Rebours, RE Brand… - Pancreatology, 2020 - Elsevier
Background Patients with chronic pancreatitis (CP) have an increased risk of pancreatic
cancer. We present the international consensus guidelines for surveillance of pancreatic …
cancer. We present the international consensus guidelines for surveillance of pancreatic …
[HTML][HTML] Curing pancreatic cancer
B Traub, KH Link, M Kornmann - Seminars in cancer biology, 2021 - Elsevier
The distinct biology of pancreatic cancer with aggressive and early invasive tumor cells, a
tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major …
tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major …
Detection, treatment, and survival of pancreatic cancer recurrence in the Netherlands: a nationwide analysis
LA Daamen, VP Groot, MG Besselink… - Annals of …, 2022 - journals.lww.com
Objective: To evaluate whether detection of recurrent pancreatic ductal adenocarcinoma
(PDAC) in an early, asymptomatic stage increases the number of patients receiving …
(PDAC) in an early, asymptomatic stage increases the number of patients receiving …
The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent
CE Forsmark, G Tang, H Xu, M Tuft… - Alimentary …, 2020 - Wiley Online Library
Background Patients with chronic pancreatitis or pancreatic cancer commonly develop
exocrine pancreatic insufficiency, and may not be adequately treated with pancreatic …
exocrine pancreatic insufficiency, and may not be adequately treated with pancreatic …
[HTML][HTML] Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer
G Roeyen, F Berrevoet, I Borbath, K Geboes, M Peeters… - ESMO open, 2022 - Elsevier
Highlights•PEI is a common condition in PC patients and should be actively looked for in PC
patients and treated with PERT.•In resected and borderline resectable patients PERT should …
patients and treated with PERT.•In resected and borderline resectable patients PERT should …